HSP 56 inhibitors belong to a specific chemical class of compounds that target and interact with the HSP 56 protein, which is a member of the heat shock protein (HSP) family. Heat shock proteins are essential for maintaining cellular homeostasis and promoting the proper folding of proteins, especially during conditions of cellular stress. HSP 56, in particular, plays a crucial role in cellular responses to stress, assisting in the correct folding of nascent proteins and preventing protein aggregation. The chemical class of HSP 56 inhibitors is characterized by a distinct set of molecular structures and functional groups that enable them to bind specifically to the active site of the HSP 56 protein. Through this interaction, HSP 56 inhibitors modulate the chaperone activity of the protein, affecting its ability to recognize and facilitate the proper folding of target proteins. By interfering with HSP 56 function, these inhibitors can have wide-ranging effects on cellular processes.
Studies involving HSP 56 inhibitors have provided valuable insights into the biological significance of HSP 56 and its involvement in cellular protein quality control mechanisms. These inhibitors have been utilized as research tools to investigate the impact of HSP 56 inhibition on protein folding, aggregation, and overall proteostasis in various cellular contexts. Additionally, researchers have explored the potential implications of HSP 56 inhibitors in understanding diseases that involve protein misfolding and aggregation, such as neurodegenerative disorders.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
One of the earliest discovered HSP90 inhibitors, found in Streptomyces bacteria. | ||||||
17-DMAG | 467214-20-6 | sc-202005 | 1 mg | $205.00 | 8 | |
Another geldanamycin derivative with better solubility. | ||||||
Radicicol | 12772-57-5 | sc-200620 sc-200620A | 1 mg 5 mg | $92.00 $333.00 | 13 | |
A natural product inhibitor of HSP90, originally isolated from the fungus, Chaetomium spp. | ||||||
NVP-AUY922 | 747412-49-3 | sc-364551 sc-364551A sc-364551B sc-364551C sc-364551D sc-364551E | 5 mg 25 mg 100 mg 250 mg 1 g 5 g | $150.00 $263.00 $726.00 $1400.00 $2900.00 $11000.00 | 3 | |
A synthetic HSP90 inhibitor developed by Novartis. | ||||||
Ganetespib | 888216-25-9 | sc-364496 sc-364496A | 10 mg 250 mg | $273.00 $1040.00 | ||
A synthetic HSP90 inhibitor that showed promise on cells in research models for various cancers. | ||||||
BIIB 021 | 848695-25-0 | sc-364434 sc-364434A | 5 mg 25 mg | $128.00 $650.00 | ||
An available HSP90 inhibitor studied for its anticancer potential. | ||||||
AT13387 | 912999-49-6 | sc-364415 sc-364415A | 10 mg 50 mg | $555.00 $1606.00 | ||
An HSP90 inhibitor being investigated for cancer research. | ||||||
IPI-504 | 857402-63-2 | sc-364512 sc-364512A | 10 mg 50 mg | $640.00 $1600.00 | ||
An HSP90 inhibitor that has undergone clinical testing for various cancers. | ||||||